Acadia Pharmaceuticals (ACAD) Operating Income Growth (1y) (2011 - 2026)
Acadia Pharmaceuticals (ACAD) Operating Income Growth (1y) (2011 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Op. Inc Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
100.00% |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
12.69% |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
75.16% |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
1.27% |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
-347.04% |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
80.62% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Acadia Pharmaceuticals |
3.68 Bn |
2.83 Bn |
243.27 Mn |
-123.93% |
| Date | Value |
|---|
| Mar 31, 2026 |
-123.93% |
| Dec 31, 2025 |
-137.86% |
| Sep 30, 2025 |
12.99% |
| Jun 30, 2025 |
6.36% |
| Mar 31, 2025 |
26.82% |
| Dec 31, 2024 |
339.28% |
| Sep 30, 2024 |
154.77% |
| Jun 30, 2024 |
902.21% |
| Mar 31, 2024 |
128.39% |
| Dec 31, 2023 |
175.86% |
| Sep 30, 2023 |
-87.18% |
| Jun 30, 2023 |
109.02% |
| Mar 31, 2023 |
52.59% |
| Dec 31, 2022 |
-150.84% |
| Sep 30, 2022 |
-101.73% |
| Jun 30, 2022 |
23.01% |
| Mar 31, 2022 |
-69.26% |
| Dec 31, 2021 |
-43.52% |
| Sep 30, 2021 |
82.19% |
| Jun 30, 2021 |
0.68% |
